ArkeaBio raises $7M in Series A1 funding, co-led by Breakthrough Energy Ventures and AgriZeroNZ, to support R&D and farmer pilot programs.
PRIVATEOct 01, 2026
Amount Raised
$7 Million
Round Type
Venture
BostonAgriculture and Farming
Investors
AgriZeroNZBreakthrough Energy Ventures
Description
ArkeaBio, a Boston-based agricultural bioscience company, raised $7M in Series A1 funding. The funds will be used to continue research and development, pilot programs for farmers, and general operations. This funding round brings the total raised to over $40 million. ArkeaBio is developing a vaccine to reduce methane emissions from cattle.
Company Information
Company
Arkeabio
Location
Boston, Massachusetts, United States
About
ArkeaBio
A pioneer in developing technology to reduce greenhouse gas (GHG) emissions from the agricultural sector
Our Mission
ArkeaBio is using innovative vaccine technologies to create solutions to reduce the on-farm methane emissions responsible for 6% of global GHG emissions. ArkeaBio technology will be integrated into proven delivery systems and farming practices to safely reduce global methane emissions from multiple ruminant species across a variety of geographies and agronomic systems.
Our Vision
Our vision is to eliminate the on-farm methane emissions from ruminant animals (including cattle sheep and goats) that are responsible for 6% of global greenhouse gas emissions.
Fundz sees it the moment Arkeabio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
BostonAgriculture and Farming